MyFinsight
Home
Blog
About
Proceeds from long-term
debt, net of issuance...
$29,979K
Proceeds from stock
option exercises
$2,356K
(60.60%↑ Y/Y)
Maturities of marketable
securities
$114,360K
(-38.46%↓ Y/Y)
Net cash provided by
financing activities
$32,335K
(-86.81%↓ Y/Y)
Net cash provided by
(used in) investing...
$21,629K
(109.79%↑ Y/Y)
Canceled cashflow
$92,731K
Net increase
(decrease) in cash, cash...
$9,763K
(115.00%↑ Y/Y)
Canceled cashflow
$44,201K
Stock-based compensation
$13,948K
(-5.65%↓ Y/Y)
Prepaid expenses and
other current assets
-$2,282K
(-128.85%↓ Y/Y)
Accrued external
research and development...
$2,187K
(579.19%↑ Y/Y)
Other accrued
expenses
$2,054K
(181.57%↑ Y/Y)
Non-cash interest
expense
$221K
(-46.75%↓ Y/Y)
Non-cash lease expense
$133K
(-41.92%↓ Y/Y)
Depreciation and
amortization
$90K
(-14.29%↓ Y/Y)
Purchases of marketable
securities
$92,731K
(-77.15%↓ Y/Y)
Net cash used in
operating activities
-$44,201K
(50.50%↑ Y/Y)
Canceled cashflow
$20,915K
Net loss
-$59,532K
(33.36%↑ Y/Y)
Accounts payable
-$4,919K
(-207.82%↓ Y/Y)
Amortization/accretion of investment
securities
$489K
(-90.50%↓ Y/Y)
Operating lease
liabilities
-$174K
(-134.32%↓ Y/Y)
Other non-cash items
$2K
Back
Back
Cash Flow
Disc Medicine, Inc. (IRON)
Disc Medicine, Inc. (IRON)
source: myfinsight.com